Award details

IAH Jenner Fellowship: Assessing the efficacy of recombinant viral vaccines to induce heterosubtypic immunity to influenza in birds

Reference	BBS/E/I/00001482
Principal Investigator / Supervisor	Dr Amy Boyd
Co-Investigators / Co-Supervisors	Dr Colin Butter
Institution	The Pirbright Institute
Department	The Pirbright Institute Department
Funding type	Research
Value (£)	220,846
Status	Completed
Type	Institute Project
Start date	08/02/2010
End date	31/08/2012
Duration	31 months

Abstract

Existing seasonal flu vaccines target the highly variable haemagglutinin (HA) surface protein. While effective, these vaccines must be administered annually and provide little if any heterosubtypic immunity. Cytotoxic T lymphocytes (CTL) targeting conserved internal antigens of influenza have been shown to mediate a cross-protective response. The Jenner Institute is currently testing Adenovirus and Modified Vaccinia Virus Ankara (MVA) encoding the internal influenza antigens NP and M1 in humans. These vaccines are designed to boost pre-existing CTL responses in adults, and through prime boost regimes may help to provide heterosubtypic immunity in infants, who unlike most adults have not been repeatedly exposed to influenza. The Jenner-IAH fellowship is part of the Jenner Institute’s One Health approach to vaccine development, developing vaccines for humans and animals in parallel. The main aim of the fellowship is to assess the efficacy of these recombinant viral vaccines in chickens, to determine if boosting CTL responses to internal antigens will induce heterosubtypic immunity in birds.

Summary

unavailable

Committee	Not funded via Committee
Research Topics	Animal Health, Immunology, Microbiology
Research Priority	X – Research Priority information not available
Research Initiative	X - not in an Initiative
Funding Scheme	X – not Funded via a specific Funding Scheme

I accept the terms and conditions of use (opens in new window)

export PDF file

back to list new search